News and blogs
413 results found.
The Big C: Cancer or Covid? - Nichola's story
Read Nichola's story about mistaking Hodgkin lymphoma. symptoms for long-Covid, beating the blood cancer into remission and taking on the Jog 26.2 mile challenge.
What is the difference between antivirals and monoclonal antibodies?
Discover more about monoclonal antibodies and antiviral drugs, and how some are being used to fight Covid.
How did the third Covid vaccine dose roll-out go so badly wrong?
We take an in-depth look at a timeline of delays, missed opportunities, and mistakes which have caused huge anxiety among people with blood cancer – and may have even led to avoidable deaths.
Covid guidance on attending events in Autumn
Read Blood Cancer UK's Covid-19 advice about attending events in Autumn, for people with blood cancer.
Re-purposing drugs could revolutionise blood cancer treatment
Discover how re-purposing drugs could help bring new treatments to people with blood cancer.
Survival rates for children and young people with leukaemia and lymphoma sees big increase
Learn more about the increase of children and young people with lymphoma and leukaemia who are surviving and beating blood cancer.
Childhood blood cancer survival rates see big improvement
Read Blood Cancer UK's analysis on the improvements in childhood blood cancer survival rates.
1 in 20 Covid intensive care patients are immunocompromised
Blood Cancer UK analysis of Intensive Care National Audit and Research Centre (ICNARC) data finds that 1 in 20 Covid intensive care patients are immunocompromised.
44% of people with blood cancer invited for potentially lifesaving third Covid vaccine dose
Blood Cancer UK's survey finds that less than half of people with blood cancer being invited for their third Covid vaccine.
New Christmas cards released in memory of Emma McKinlay
Blood Cancer UK have released new Christmas card designs in memory of the late artist Emma McKinlay.
Blood cancer and your employment rights
Ben Goodall from Acas explains how employees with blood cancer are protected by law, and how to handle discussions with your employer about the impact blood cancer has on your working life, especially during the current pandemic.
Supporting people with blood cancer to make decisions around clinical trials
Find out how Millie, an Advanced Nurse Practitioner, helps people with blood cancer take decisions on blood cancer clinical trials.
What should you do if you have blood cancer and cannot get a third Covid vaccine dose?
With many people reporting issues with the rollout of third doses of the vaccine, we’ve set out what you can do right now to try to get your third dose if you have not already been invited for it.
What does Sajid Javid’s letter to the clinically extremely vulnerable mean?
We've read the 2,000 word letter, digested it, and sum up the key points in 179 words.
My birthday surprise… blood cancer
Due to the severity of his condition, Sunny didn't have time to digest the news of his diagnosis. Now, he has some advice for you.
Blood Cancer UK research strategy - your questions answered
Read more about Blood Cancer UK's research strategy, find out how we will allocate funding, and how soon research should deliver impact for patients.
Catching Covid with blood cancer - Philip's story
Hear how Philip's family did everything they could to shelter him from Covid after he was diagnosed with Myelodysplasia (MDS), and how the vaccine offer enough protection.
I put my symptoms down to being pregnant, but it was actually blood cancer.
Read Jemma's story about how her Hodgkin lymphoma symptoms were mistaken as side effects of being pregnant.
The blood cancer jigsaw: how we start to piece together the bigger picture
Read more about Blood Cancer UK's article on the similarities between blood cancer treatments, and how some drugs and research are having an impact across multiple conditions.
Blood cancer clinical trials - Everything you didn't know you needed to know
Read Professor Andrew Pettitt's piece on blood cancer clinical trials, where he explains the benefits, concerns and availability of clinical trials to people with blood cancer..
